Speaker
Professor, Georgetown University
Nagi Ayad, Georgetown University, spoke at 8th RAS-Targeted Drug Development Summit (Boston, United States of America, 8–10 Sept 2026) in the session “Expanding the Druggable Landscape: Targeting Signalling, Cytoskeletal & Chromatin Pathways to Unlock Next-Generation RAS Combination Strategies”.
8–10 Sept 2026Boston, United States of America
Chief Technology Officer, Anocca AB
Executive Director & Head of Enzalutamide, Medical Affairs (US), Astellas Pharma
Senior Director, Translational & Preclinical Research, Verastem, inc
Chief Scientific Officer, Elicio Therapeutics
Senior Research, Pharmacology Investigator, Incyte Corporation
Chief Scientific Officer, KAYAK
This profile is built from conference programmes published on kongre.net. It has not been claimed or confirmed by Nagi Ayad, and it lists only the talks, sessions and presentations named in those programmes.
Is this you? Claim this profile — every request is read by a person before anything is linked.
To ask for a correction or for this profile to be removed, email [email protected].